Related Experiment Video
Updated: Jun 29, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Bacterial meningitis in children
Xavier Sáez-Llorens1, George H McCracken
1University of Panama School of Medicine, Hospital del Niño, Panama City, Panama. xsaezll@cwpanama.net
Insights
Bacterial meningitis is rare in developed nations but devastating in developing countries. Research is crucial for new treatments and worldwide vaccine implementation to prevent this infection.
Area of Science:
- Pediatric infectious diseases
- Microbiology
- Epidemiology
Background:
- Bacterial meningitis epidemiology, microbiology, pathophysiology, clinical manifestations, diagnosis, management, prognosis, and prevention are reviewed, focusing on pediatric cases.
- Changes in bacterial meningitis landscape include reduced Haemophilus influenzae, emerging antibiotic-resistant Streptococcus pneumoniae, and increased Neisseria meningitidis outbreaks.
- Significant research is underway for conjugate vaccines against pneumococcal and meningococcal meningitis.
Purpose of the Study:
- To provide a comprehensive review of bacterial meningitis, emphasizing the pediatric population.
- To highlight the evolving challenges and research directions in bacterial meningitis.
Main Methods:
- Literature review encompassing epidemiology, microbiology, pathophysiology, clinical aspects, diagnosis, management, prognosis, and prevention.
- Analysis of recent trends including antibiotic resistance, vaccine development, and global disparities.
Main Results:
- Bacterial meningitis is now uncommon in developed countries but remains a severe threat in developing nations.
- Emergence of multidrug-resistant and vancomycin-tolerant pneumococci, alongside meningococcal outbreaks, presents ongoing challenges.
- Development of conjugate vaccines for pneumococcal and meningococcal meningitis shows promise.
Conclusions:
- Despite advances, bacterial meningitis requires continued basic and clinical research for novel antimicrobial and anti-inflammatory agents.
- Global distribution and implementation of effective vaccines are essential for preventing bacterial meningitis worldwide.
Abstract:
This review comprises aspects of the epidemiology, microbiology, pathophysiology, clinical manifestations, diagnosis, management, prognosis, and prevention of bacterial meningitis, with emphasis on the paediatric population. The beginning of this millennium has witnessed the virtual disappearance of Haemophilus invasive disease in some countries, emergence of pneumococcal strains that are resistant to multiple antibiotics, isolation of pneumococci with tolerance to vancomycin, outbreaks and clusters of meningococcal meningitis in several geographical areas, and intense research in development of effective conjugate pneumococcal and meningococcal vaccines. Bacterial meningitis has become an uncommon disease in the developed world. Unfortunately, because of limited economic resources and poor living conditions, many developing countries are still affected by the devastating consequences of this life-threatening systemic infection. Basic and clinical research is needed to discover new antimicrobial and anti-inflammatory agents to improve outcome from disease. Novel strategies are needed to distribute and implement effective vaccines worldwide to prevent bacterial meningitis.
Related Concept Videos
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction

